Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ingrid Fadum Kjønstad
Observed names:
I F Kjønstad,
I. Fadum Kjønstad,
Ingrid F. Kjønstad
Institution:
Norwegian Institute of Public Health
Observed institutions:
Norwegian Institute of Public Health,
University of Oslo,
Norwegian University of Science and Technology
ORCID:
0000-0001-5306-3492
Observed ORCID:
0000-0001-5306-3492
OpenAlex ID:
A5081368228
Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness
2017
·
Marit Bugge
, Bjarte Bergstrom
, et al.
·
Journal of Biological Chemistry
·
70
PDF
Lysine methylation by the mitochondrial methyltransferase FAM173B optimizes the function of mitochondrial ATP synthase
2018
·
Jędrzej M. Małecki
, Hanneke L.D.M. Willemen
, et al.
·
Journal of Biological Chemistry
·
29
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study
2023
·
Anthony Ravussin
, Anna Hayman Robertson
, et al.
·
The Lancet Healthy Longevity
·
24
PDF
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
2024
·
Asia-Sophia Wolf
, Kristin H. Bjørlykke
, et al.
·
EBioMedicine
·
15
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
2023
·
Asia-Sophia Wolf
, Anthony Ravussin
, et al.
·
JCI Insight
·
15
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly
2024
·
Ratnadeep Mukherjee
, Linn Margrethe Eggesbø
, et al.
·
npj Vaccines
·
6
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
2024
·
Hilde S. Ørbo
, Taissa de Matos Kasahara
, et al.
·
The Lancet Regional Health - Europe
·
2
P1056 T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients with inflammatory bowel disease on TNF inhibitor treatment, a prospective cohort study
2024
·
K H Bjørlykke
, A S Wolf
, et al.
·
Journal of Crohn s and Colitis
·
1
PDF
Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections
2026
·
Anna Hayman Robertson
, Asia-Sophia Wolf
, et al.
·
Vaccine
POS0573 NEUTRALISING ANTIBODY RESPONSES TO BIVALENT SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY
2024
·
H.S. Ørbo
, T.M. Kasahara
, et al.
·
Annals of the Rheumatic Diseases
POS0090 CELLULAR AND HUMORAL RESPONSES RESTORED BY UPDATED SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY
2024
·
H.S. Ørbo
, A.S. Wolf
, et al.
·
Annals of the Rheumatic Diseases
Op0085 Longitudinal T Cell Responses to a Series of Four Sars-cov-2 Vaccine Doses or Covid-19 in Patients on Tnf Inhibitors
2023
·
H. Ørbo
, A.S.F.M. Wolf
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
12
Citation count:
162
H-index:
6
I10-index:
5
Year
Topic
Type